Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.

Identifieur interne : 000310 ( Main/Exploration ); précédent : 000309; suivant : 000311

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.

Auteurs : Dandan Wu [République populaire de Chine] ; Xuexian O. Yang [États-Unis]

Source :

RBID : pubmed:32205092

Abstract

COVID-19 emerges as a pandemic disease with high mortality. Development of effective prevention and treatment is an urgent need. We reviewed TH17 responses in patients with SARS-CoV-2 and proposed an FDA approved JAK2 inhibitor Fedratinib for reducing mortality of patients with TH17 type immune profiles.

DOI: 10.1016/j.jmii.2020.03.005
PubMed: 32205092


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.</title>
<author>
<name sortKey="Wu, Dandan" sort="Wu, Dandan" uniqKey="Wu D" first="Dandan" last="Wu">Dandan Wu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA; College of Agronomy, Hunan Agricultural University, Changsha, Hunan, 410128, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA; College of Agronomy, Hunan Agricultural University, Changsha, Hunan, 410128</wicri:regionArea>
<wicri:noRegion>410128</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yang, Xuexian O" sort="Yang, Xuexian O" uniqKey="Yang X" first="Xuexian O" last="Yang">Xuexian O. Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA. Electronic address: xyang@salud.unm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131</wicri:regionArea>
<wicri:noRegion>87131</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32205092</idno>
<idno type="pmid">32205092</idno>
<idno type="doi">10.1016/j.jmii.2020.03.005</idno>
<idno type="wicri:Area/PubMed/Corpus">000069</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000069</idno>
<idno type="wicri:Area/PubMed/Curation">000069</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000069</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000288</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000288</idno>
<idno type="wicri:Area/Ncbi/Merge">001536</idno>
<idno type="wicri:Area/Ncbi/Curation">001536</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001536</idno>
<idno type="wicri:Area/Main/Merge">000312</idno>
<idno type="wicri:Area/Main/Curation">000310</idno>
<idno type="wicri:Area/Main/Exploration">000310</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.</title>
<author>
<name sortKey="Wu, Dandan" sort="Wu, Dandan" uniqKey="Wu D" first="Dandan" last="Wu">Dandan Wu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA; College of Agronomy, Hunan Agricultural University, Changsha, Hunan, 410128, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA; College of Agronomy, Hunan Agricultural University, Changsha, Hunan, 410128</wicri:regionArea>
<wicri:noRegion>410128</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yang, Xuexian O" sort="Yang, Xuexian O" uniqKey="Yang X" first="Xuexian O" last="Yang">Xuexian O. Yang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131, USA. Electronic address: xyang@salud.unm.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, 87131</wicri:regionArea>
<wicri:noRegion>87131</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</title>
<idno type="eISSN">1995-9133</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">COVID-19 emerges as a pandemic disease with high mortality. Development of effective prevention and treatment is an urgent need. We reviewed TH17 responses in patients with SARS-CoV-2 and proposed an FDA approved JAK2 inhibitor Fedratinib for reducing mortality of patients with TH17 type immune profiles.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Wu, Dandan" sort="Wu, Dandan" uniqKey="Wu D" first="Dandan" last="Wu">Dandan Wu</name>
</noRegion>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Yang, Xuexian O" sort="Yang, Xuexian O" uniqKey="Yang X" first="Xuexian O" last="Yang">Xuexian O. Yang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000310 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000310 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32205092
   |texte=   TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32205092" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021